The increased risk of acute leukemia in individuals with Down syndrome has been recognized for decades. In a review article published by Verma et al in JAMA Oncology, researchers review clinical presentation, current treatment, and recent biological insights for children, adolescents, and young adults with acute leukemia and Down syndrome.
